GPCR/G protein


All GPCRs share a common seven trans-membrane structure. GPCRs are associated with heterotrimeric G-proteins which are GTP-binding proteins made of alpha, beta, and gamma subunits. When a ligand binds to GPCR, it activates the attached G-protein, the GDP is replaced with GTP. The activated G-protein then dissociates into an alpha and a beta-gamma complex which activates downstream signaling pathways. These intracellular signaling pathways include cAMP/PKA, calcium/NFAT, phospholipase C, protein tyrosine kinases, MAP kinases, PI-3-kinase, nitric oxide/cGMP, Rho, and JAK/STAT.
GPCRs are one of the most important therapeutic targets for various diseases, over 30% of all modern medicinal drugs target this family. Aberrant GPCR functions are involved in pathological conditions such as neurological, immunological and hormonal disorders. A large number of GPCRs have been identified, but whose ligands are not known, are classified as orphan receptors.
-
B5667 TT 232Summary: sst1/sst4 somatostatin receptors agonist -
B5683 RFRP 3 (human)Summary: NPFF1 receptor agonist -
B5703 FSLLRY-NH2 TFASummary: PAR2 peptide antagonist -
B5768 PG 106Summary: hMC3 receptor antagonist -
B5803 ANQ 11125Summary: Motilin receptor antagonist,selective -
B5807 PG 931Summary: melanocortin 4 (MC4) receptor agonist -
B5808 OXA (17-33)Summary: orexin OX1 receptor agonist -
B5810 CTCE 9908Summary: CXCR4 antagonist -
B5813 DMNPE-caged ATP diammonium saltSummary: DMNPE-caged ATP -
B6274 N-AcetyltryptamineTarget: Melatonin ReceptorsSummary: melatonin receptor modulator

